APO RESEARCH · REPORT
Clinical Trial
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
Product & engineering
Understand the product.
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
Selected research
Market Structure
Global Clinical Trial Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
Report Includes
Read the full market overview
This report provides an overview of the global Clinical Trial market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Clinical Trial and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Clinical Trial revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Clinical Trial market size, projected growth trends, production technologies, key applications, and end-use industries.
Clinical Trial Segment by Company
Fisher Clinical Services
Myoderm
Bilcare
CliniChain
Ancillare
MESM
ERG Holding
Apex Medical Research
Parexel
PRA Health
LabCorp (Covance)
Marken
AmerisourceBergen (World Courier)
Clinical Trial Segment by Type
Instruments(Products)
Consumables
Others
Clinical Trial Segment by Application
Procurement and Supplies
Rentals
Others
Clinical Trial Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trial market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clinical Trial and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trial.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Clinical Trial in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Clinical Trial industry.
Chapter 3: Detailed analysis of Clinical Trial companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Trialrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Instruments(Products)
- Consumables
- Others
Applications
- Procurement and Supplies
- Rentals
- Others
Companies covered
- Fisher Clinical Services
- Myoderm
- Bilcare
- CliniChain
- Ancillare
- MESM
- ERG Holding
- Apex Medical Research
- Parexel
- PRA Health
- LabCorp (Covance)
- Marken
- AmerisourceBergen (World Courier)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Clinical Trial Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Instruments(Products)
- 1.2.3 Consumables
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Clinical Trial Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Procurement and Supplies
- 1.3.3 Rentals
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Clinical Trial Growth Trends by Region
- 1.5.1 Global Clinical Trial Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Clinical Trial Market Size by Region (2021-2026)
- 1.5.3 Clinical Trial Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Clinical Trial Market Dynamics
- 2.1 Clinical Trial Industry Trends
- 2.2 Clinical Trial Industry Drivers
- 2.3 Clinical Trial Industry Opportunities and Challenges
- 2.4 Clinical Trial Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Clinical Trial Revenue by Company (2021-2026)
- 3.2 Global Clinical Trial Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Clinical Trial Key Company Head office and Area Served
- 3.4 Global Clinical Trial Company, Product Type & Application
- 3.5 Global Clinical Trial Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Clinical Trial Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Clinical Trial Players Market Share by Revenue in 2025
- 3.6.3 2025 Clinical Trial Tier 1, Tier 2, and Tier 3
4 Clinical Trial Market by Type
- 4.1 Global Clinical Trial Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Clinical Trial Market Size by Type (2021-2032)
- 4.3 Global Clinical Trial Market Size Share by Type (2021-2032)
5 Clinical Trial Market by Application
- 5.1 Global Clinical Trial Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Clinical Trial Market Size by Application (2021-2032)
- 5.3 Global Clinical Trial Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Fisher Clinical Services
- 6.1.1 Fisher Clinical Services Company Information
- 6.1.2 Fisher Clinical Services Business Overview
- 6.1.3 Fisher Clinical Services Clinical Trial Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Fisher Clinical Services Clinical Trial Product Portfolio
- 6.1.5 Fisher Clinical Services Recent Developments
- 6.2 Myoderm
- 6.2.1 Myoderm Company Information
- 6.2.2 Myoderm Business Overview
- 6.2.3 Myoderm Clinical Trial Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Myoderm Clinical Trial Product Portfolio
- 6.2.5 Myoderm Recent Developments
- 6.3 Bilcare
- 6.3.1 Bilcare Company Information
- 6.3.2 Bilcare Business Overview
- 6.3.3 Bilcare Clinical Trial Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Bilcare Clinical Trial Product Portfolio
- 6.3.5 Bilcare Recent Developments
- 6.4 CliniChain
- 6.4.1 CliniChain Company Information
- 6.4.2 CliniChain Business Overview
- 6.4.3 CliniChain Clinical Trial Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 CliniChain Clinical Trial Product Portfolio
- 6.4.5 CliniChain Recent Developments
- 6.5 Ancillare
- 6.5.1 Ancillare Company Information
- 6.5.2 Ancillare Business Overview
- 6.5.3 Ancillare Clinical Trial Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Ancillare Clinical Trial Product Portfolio
- 6.5.5 Ancillare Recent Developments
- 6.6 MESM
- 6.6.1 MESM Company Information
- 6.6.2 MESM Business Overview
- 6.6.3 MESM Clinical Trial Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 MESM Clinical Trial Product Portfolio
- 6.6.5 MESM Recent Developments
- 6.7 ERG Holding
- 6.7.1 ERG Holding Company Information
- 6.7.2 ERG Holding Business Overview
- 6.7.3 ERG Holding Clinical Trial Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 ERG Holding Clinical Trial Product Portfolio
- 6.7.5 ERG Holding Recent Developments
- 6.8 Apex Medical Research
- 6.8.1 Apex Medical Research Company Information
- 6.8.2 Apex Medical Research Business Overview
- 6.8.3 Apex Medical Research Clinical Trial Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Apex Medical Research Clinical Trial Product Portfolio
- 6.8.5 Apex Medical Research Recent Developments
- 6.9 Parexel
- 6.9.1 Parexel Company Information
- 6.9.2 Parexel Business Overview
- 6.9.3 Parexel Clinical Trial Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Parexel Clinical Trial Product Portfolio
- 6.9.5 Parexel Recent Developments
- 6.10 PRA Health
- 6.10.1 PRA Health Company Information
- 6.10.2 PRA Health Business Overview
- 6.10.3 PRA Health Clinical Trial Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 PRA Health Clinical Trial Product Portfolio
- 6.10.5 PRA Health Recent Developments
- 6.11 LabCorp (Covance)
- 6.11.1 LabCorp (Covance) Company Information
- 6.11.2 LabCorp (Covance) Business Overview
- 6.11.3 LabCorp (Covance) Clinical Trial Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 LabCorp (Covance) Clinical Trial Product Portfolio
- 6.11.5 LabCorp (Covance) Recent Developments
- 6.12 Marken
- 6.12.1 Marken Company Information
- 6.12.2 Marken Business Overview
- 6.12.3 Marken Clinical Trial Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Marken Clinical Trial Product Portfolio
- 6.12.5 Marken Recent Developments
- 6.13 AmerisourceBergen (World Courier)
- 6.13.1 AmerisourceBergen (World Courier) Company Information
- 6.13.2 AmerisourceBergen (World Courier) Business Overview
- 6.13.3 AmerisourceBergen (World Courier) Clinical Trial Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 AmerisourceBergen (World Courier) Clinical Trial Product Portfolio
- 6.13.5 AmerisourceBergen (World Courier) Recent Developments
7 North America
- 7.1 North America Clinical Trial Market Size (2021-2032)
- 7.2 North America Clinical Trial Market Size by Type
- 7.2.1 North America Clinical Trial Market Size by Type (2021-2026)
- 7.2.2 North America Clinical Trial Market Size by Type (2027-2032)
- 7.2.3 North America Clinical Trial Market Share by Type (2021-2032)
- 7.3 North America Clinical Trial Market Size by Application
- 7.3.1 North America Clinical Trial Market Size by Application (2021-2026)
- 7.3.2 North America Clinical Trial Market Size by Application (2027-2032)
- 7.3.3 North America Clinical Trial Market Share by Application (2021-2032)
- 7.4 North America Clinical Trial Market Size by Country
- 7.4.1 North America Clinical Trial Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Clinical Trial Market Size by Country (2021-2026)
- 7.4.3 North America Clinical Trial Market Size by Country (2027-2032)
- 7.4.4 North America Clinical Trial Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Clinical Trial Market Size (2021-2032)
- 8.2 Europe Clinical Trial Market Size by Type
- 8.2.1 Europe Clinical Trial Market Size by Type (2021-2026)
- 8.2.2 Europe Clinical Trial Market Size by Type (2027-2032)
- 8.2.3 Europe Clinical Trial Market Share by Type (2021-2032)
- 8.3 Europe Clinical Trial Market Size by Application
- 8.3.1 Europe Clinical Trial Market Size by Application (2021-2026)
- 8.3.2 Europe Clinical Trial Market Size by Application (2027-2032)
- 8.3.3 Europe Clinical Trial Market Share by Application (2021-2032)
- 8.4 Europe Clinical Trial Market Size by Country
- 8.4.1 Europe Clinical Trial Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Clinical Trial Market Size by Country (2021-2026)
- 8.4.3 Europe Clinical Trial Market Size by Country (2027-2032)
- 8.4.4 Europe Clinical Trial Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Clinical Trial Market Size (2021-2032)
- 9.2 China Clinical Trial Market Size by Type
- 9.2.1 China Clinical Trial Market Size by Type (2021-2026)
- 9.2.2 China Clinical Trial Market Size by Type (2027-2032)
- 9.2.3 China Clinical Trial Market Share by Type (2021-2032)
- 9.3 China Clinical Trial Market Size by Application
- 9.3.1 China Clinical Trial Market Size by Application (2021-2026)
- 9.3.2 China Clinical Trial Market Size by Application (2027-2032)
- 9.3.3 China Clinical Trial Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Clinical Trial Market Size (2021-2032)
- 10.2 Asia Clinical Trial Market Size by Type
- 10.2.1 Asia Clinical Trial Market Size by Type (2021-2026)
- 10.2.2 Asia Clinical Trial Market Size by Type (2027-2032)
- 10.2.3 Asia Clinical Trial Market Share by Type (2021-2032)
- 10.3 Asia Clinical Trial Market Size by Application
- 10.3.1 Asia Clinical Trial Market Size by Application (2021-2026)
- 10.3.2 Asia Clinical Trial Market Size by Application (2027-2032)
- 10.3.3 Asia Clinical Trial Market Share by Application (2021-2032)
- 10.4 Asia Clinical Trial Market Size by Country
- 10.4.1 Asia Clinical Trial Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Clinical Trial Market Size by Country (2021-2026)
- 10.4.3 Asia Clinical Trial Market Size by Country (2027-2032)
- 10.4.4 Asia Clinical Trial Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Clinical Trial Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Clinical Trial Market Size by Type
- 11.2.1 South America, Middle East & Africa Clinical Trial Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Clinical Trial Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Clinical Trial Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Clinical Trial Market Size by Application
- 11.3.1 South America, Middle East & Africa Clinical Trial Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Clinical Trial Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Clinical Trial Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Clinical Trial Market Size by Country
- 11.4.1 South America, Middle East & Africa Clinical Trial Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Clinical Trial Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Clinical Trial Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Clinical Trial Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst